Clinical Trial Update: Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing HIV integrase inhibitor monotherapy to placebo over 10 days in integrase-naive HIV-1 infected adults has completed; sponsor GlaxoSmith…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Investigational HIV drug (name not disclosed)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus, HIV-1 Infection | Phase 2 | Status: COMPLETED